Feasibility and Utility of a Structured Guide for Cannabis Tolerance Breaks in Young Adults

Competing Interest Statement

This research was funded by a grant from the State of Vermont (TF). Effort of the authors was also supported by the National Institute on Drug Abuse of the National Institutes of Health under award numbers U54DA036114 (JAS), R21DA051943 (ACV), and P30DA029926 (AJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the State of Vermont. TF is the owner of Cum Laude Consulting LLC, which received a grant from the State of Vermont to investigate the T-Break Guide. Those funds were then subcontracted to the University of Vermont for this research.

Clinical Trial

NCT05382273

Funding Statement

This research was funded by a grant from the State of Vermont (TF). Effort of the authors was also supported by the National Institute on Drug Abuse of the National Institutes of Health under award numbers U54DA036114 (JAS), R21DA051943 (ACV), and P30DA029926 (AJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the State of Vermont.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of University of Vermont gave ethical approval for this work (STUDY00001489)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes